Juvenescence joins Banco Português de Fomento and 200M Fund in co-investment in Chrysea Laboratories
Juvenescence joins the 200M Fund portfolio in the investment in Chrysea Labs (“Chrysea”), a synthetic biology company developing high-value and difficult to source natural products, using proprietary synthetic biology platforms.